Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 501 36 0. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel total synthesis of trans-resveratrol via Wittig-Horner. High yield, mild conditions, scalable production for pharmaceutical and nutraceutical applications.
Patent CN102126931B details a scalable Horner-Wadsworth-Emmons route for Resveratrol, offering cost reduction and high purity for pharmaceutical manufacturing.